Chemours Shareholders' Equity History
CC / Materials|10 years of SEC 10-K data (FY2016-FY2025)
$566M in FY2025 with a 5-year CAGR of -7.0%.
Declined from $721M to $566M over the past 2 years.
Chemours's shareholders' equity of $566M is lower than 78% of companies in the Materials sector (FY2025). Shareholders' Equity has declined for 3 consecutive years, from $1.1B in FY2022 to $566M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
- 3-Year CAGR
- -20.0%
- 5-Year CAGR
- -7.0%
- 10-Year CAGR
- -
Shareholders' Equity Trend
Bottom 22% in MaterialsTop 78% of 118This company $566.0M Sector average $4.5B
▼
-87.4% below sector average
Key Insights
- Chemours's shareholders' equity has declined for 3 consecutive years.
- 5-year CAGR of -7.0%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 0.9% year-over-year.
- Ranks #92 out of 118 companies in the Materials sector.
Annual Data
| Year | Shareholders' Equity | YoY Growth |
|---|---|---|
| FY2025 | $566.0M | -0.9% |
| FY2024 | $571.0M | -20.8% |
| FY2023 | $721.0M | -34.9% |
| FY2022 | $1.1B | +2.4% |
| FY2021 | $1.1B | +33.0% |
| FY2020 | $813.0M | +18.0% |
| FY2019 | $689.0M | -32.1% |
| FY2018 | $1.0B | +17.9% |
| FY2017 | $860.0M | +760.0% |
| FY2016 | $100.0M | -20.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026